Deutsche Bank Ag\ Ligand Pharmaceuticals Inc Put Options Transaction History

Deutsche Bank Ag\

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $6,657 - $8,019	-62 Reduced 11.03%	500 $57,000
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $99,997 - $134,491	-944 Reduced 62.68%	562 $70,000
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $193,310 - $409,827	1,506 New	1,506 $204,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.